Guillonneau; Claude

Patent Applications and Registrations

Patent applications and USPTO patent grants for Guillonneau; Claude.The latest application filed is for "polysubstituted pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamine compounds, a process for their preparation and pharmaceutical compositions containing them".

Company Profile

0.7.6

Guillonneau; Claude - Clamart FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Polysubstituted Pyridinylaminoalkylene- and Pyridinyloxyalkylene-Cyclopropanamine Compounds, a Process for Their Preparation and Pharmaceutical Compositions Containing Them App 20100317698 - Goldstein; Solo ; et al.	2010-12-16
Polysubstituted 1,1-pyridylaminocyclopropanamine compounds App 20080146621 - Goldstein; Solo ; et al.	2008-06-19
Polysubstituted 1,1-pyridylaminocyclopropanamine compounds Grant 7,388,022 - Goldstein , et al. June 17, 2	2008-06-17
Polysubstituted 1,1-pyridyloxycyclopropanamine compounds Grant 7,348,344 - Goldstein , et al. March 25, 2	2008-03-25
Polysubstituted 1,1-pyridylamioncyclopropanamine compounds App 20070027192 - Goldstein; Solo ; et al.	2007-02-01
Polysubstituted 1,1-pyridyloxycyclopropanamine compounds App 20070027191 - Goldstein; Solo ; et al.	2007-02-01
1,1- and 1,2-disubstituted cyclopropane compounds Grant 6,943,184 - Goldstein , et al. September 13, 2	2005-09-13
1,1-and 1,2-disubstituted cyclopropane compounds App 20050032845 - Goldstein, Solo ; et al.	2005-02-10
1,1- and 1,2-disubstituted cyclopropane compounds App 20020022643 - Goldstein, Solo ; et al.	2002-02-21
Pharmaceutical compositions and a method for the treatment of memory disorders, intellectual disorders of ageing and Alzheimer's disease Grant 5,173,491 - Kamoun , et al. December 22, 1	1992-12-22
Tetrahydroquinoline morpholine compounds, compositions and use Grant 4,782,054 - Regnier , et al. November 1, 1	1988-11-01
Antimigraine 8-[3-(4-aminocarbonyl piperazino and piperidino) propyl[xanthines Grant 4,599,338 - Regnier , et al. July 8, 1	1986-07-08
Xanthine compounds Grant 4,548,820 - Regnier , et al. October 22, 1	1985-10-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.